Abstract
Diffuse large B-cell lymphoma (DLBCL), the most common type of non-Hodgkin lymphoma (NHL), is a heterogeneous group of B-cell lymphomas with several distinctive subsets. Most of lymphoma cases in developing and tropical countries are aggressive lymphomas comprising Burkitt lymphoma and DLBCL. As several entities belong to the DLBCL category identified by the WHO classification, the identification of DLBCL is important for the diagnosis and the treatment. In low- and medium-income countries, the development of molecular and genetic techniques is still insufficient for an accurate diagnosis. However, diligent application of morphology and usage of a limited panel of immunohistochemistry and an algorithmic approach allow the identification of most subcategories and clinicopathologic entities of DLBCL.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Naresh K, Magrath I, Raphaël M, Leoncini L (2012) Aggressive B-cell lymphomas. Adv Hematol 2012:604603
Naresh K, Advani S, Adde M et al (2004) Report of an international network of cancer treatment and research workshop on non Hodgkin’s lymphoma in developing countries. Blood Cells Mol Dis 33:330–337
Rogena E, De Falco G, Schurfeld K, Leoncini L (2011) A review of the trends of lymphomas in the equatorial belt of Africa. Hematol Oncol 3:111–115
Sissolak G, Jurirtz J, Sissolak D, Wood L, Jacobs P (2010) Lymphoma-emerging reality in sub-Saharan Africa. Transfus Apher Sci 42:141–150
Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds) (2008) WHO classification of tumours of hematopoietic and lymphoid tissues. IARC, Lyon
Sasco AJ, Jacquet A, Boidin E et al (2010) The challenge of AIDS-related malignancies in Sub-Saharan Africa. PLoS One 5(1), e8621
Vishnu P, Aboulafia DM (2012) AIDS-related non-Hodgkin’s lymphoma in the era of highly active antiretroviral therapy. Adv Hematol 2012:604603
Mwakigonia AR, Kaaya EE, Heiden T et al (2010) Tanzania malignant lymphomas: WHO classification, presentation, ploidy, proliferation and HIV/EBV association. BMC Cancer 10:344
Morgan EA, Nascimento AF (2012) Anaplastic lymphoma kinase-positive large B-cell lymphomas: an underrecognized aggressive lymphoma. Adv Hematol 2012:529572
Hans CP, Weisenburger DD, Greiner TC et al (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103:275–282
Morton LM, Cerhab JR, Hartge P et al (2011) Immunostaining to identify molecular subtypes of diffuse large B-cell lymphoma in a population – epidemiologic study in the pre-rituximab era. Int J Epidemiol Genet 2:245–252
Rossi M, Laginestra MA, Gazzola A, Sapienza MR, Pileri SA, Piccaluga PP (2012) Molecular profiling of aggressive lymphomas. Adv Hematol 2012:464680
Jain P, Fayad LE, Rosenwald A, Young KH, O’Brien S (2013) Recent advances in de novo CD5+ diffuse large B-cell lymphoma. Am J Hematol 88:798–802
Tumwine L, Campidelli C, Righi S, Neda S, Byarugaba W, Pileri SA (2008) B-cell non Hodgkin lymphomas in Uganda: an immunohistochemical appraisal on tissue microarray. Hum Pathol 39:816–823
Al-Kawaaz M, Mathew S, Liu Y et al (2015) Cyclin D1-positive diffuse large B-cell lymphoma with IGH-CCND1 translocation and BCL6 rearrangement: a report of 2 cases. Am J Clin Pathol 143:288–299
Chisholm KM, Bangs CD, Bacchi CE, Kirsch HM, Cherre A, Natkunam Y (2015) Expression profiles of MYC protein and MYC rearrangement in lymphomas. Am J Surg Pathol 39:294–303
Ott G, Rosenwald A, Campo E (2013) Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classification. Hematol Am Soc Hematol Edu Prog 2013:575–583
Swerdlow S (2014) Diagnosis of ‘double hit’ diffuse large B-cell lymphoma and B-cell lymphoma unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma: when and how, FISH versus IHC. Hematol Am Soc Hematol Educ Prog 2014(1):90–99
Testoni M, Zucca E, Young KH, Bertoni F (2015) Genetic lesions in diffuse large B-cell lymphomas. Ann Oncol 2015 26(6):1069–1080. pil :mdv019{Epub ahead of print}
Gerstner ER, Batchelor TT (2010) Primary central nervous system lymphoma. Arch Neurol 67:291–297
Ok CY, Papathomas TG, Medeiros LJ, Young KH (2013) EBV-positive diffuse large B-cell lymphoma of the elderly. Blood 122:328–340
Martelli M, Ferreri AJ, Johnson P (2008) Primary mediastinal large B-cell lymphoma. Crit Rev Oncol Hematol 68:256–263
Nador RG, Cesarman E, Chadburn A, Dawson DB, Ansari MQ, Said J, Knowles DM (1996) Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi’s sarcoma-associated herpes virus. Blood 88:645–656
Naresh K, Ibrahim HA, Lazzi S et al (2011) Diagnosis of Burkitt lymphoma using an algorithmic approach-applicable in both resource-poor and resource – rich countries. Br J Haematol 154:770–776
Naresh K, Raphaël M, Ayers L et al (2011) Lymphomas in Sub-Saharan Africa – what can we learn and how we help in improving diagnosis, managing patients and fostering translational research. Br J Haematol 154:696–703
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Naresh, K., Raphaël, M., Auberger, E., Githanga, J. (2015). Diagnosis of Diffuse Large B-Cell Lymphoma. In: Droz, JP., Carme, B., Couppié, P., Nacher, M., Thiéblemont, C. (eds) Tropical Hemato-Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-18257-5_22
Download citation
DOI: https://doi.org/10.1007/978-3-319-18257-5_22
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-18256-8
Online ISBN: 978-3-319-18257-5
eBook Packages: MedicineMedicine (R0)